As yet another study shows that nonadherence to statin therapy can carry grave consequences, Dr. Steven Nissen argues it’s time for physicians to actively counter online misinformation about the drugs.
A recent study of five heart disease risk calculators found significant risk overestimation remains a problem. A Cleveland Clinic expert outlines how these imperfect tools might fit into practice.
A Cleveland Clinic analysis of IVUS images from eight large clinical trials suggests that coronary artery calcification might in fact be cardioprotective. We explore implications for research and practice.
Many patients previously statin-intolerant can tolerate a subsequent statin trial. Intermittent statin dosing can be effective and may even result in the reduction of LDL-C levels and the attainment of LDL-C goals